GlassScriptPhysician profile
Travis W Mccoy
NPI 1174676001
$55,263.13
in general payments reported to CMS, 2019-2025
9 companies · $19.27 in 2025
The $19.27 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $15K · 2021: $2,351 · 2022: $234 · 2023: $286 · 2024: $82.83 · 2025: $19.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $52,895.04 | 2019-2022 | |
| Tosoh Bioscience, INC. | $1,332.00 | 2019 | |
| Emd Serono, INC. | $439.12 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $232.69 | 2019-2023 | Menopur |
| Coopersurgical, INC. | $192.01 | 2022-2025 | Stripper |
| Intuitive Surgical, INC. | $69.85 | 2022 | |
| Galen US INC | $54.34 | 2019-2020 | |
| Minerva Surgical, INC | $30.51 | 2021 | |
| Roche Diagnostics Corporation | $17.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Mccoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.